# The Belgian Molecular Profiling Program of Metastatic Cancer for Clinical Decision and Treatment Assignment

> **NCT03873103** · — · UNKNOWN · sponsor: **The Belgian Society of Medical Oncology** · enrollment: 1000 (estimated)

## Conditions studied

- Metastatic Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03873103
- **Lead sponsor:** The Belgian Society of Medical Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-31
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2021-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03873103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03873103, "The Belgian Molecular Profiling Program of Metastatic Cancer for Clinical Decision and Treatment Assignment". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03873103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*